Results 1 to 10 of about 54,214 (96)

RETRACTED ARTICLE: Association of the location and initial degree of malignant central airway stenosis with the risk of severe restenosis after interventional bronchoscopy

BMC Pulmonary Medicine, 2021
Background Therapeutic bronchoscopy is one of the effective methods in the treatment and management of malignant central airway stenosis (MCAS). However, restenosis after therapeutic bronchoscopy frequently occurs and severe restenosis (SR) can be life ...
Saibin Wang, Renzhi Zhou, Siyao Zhu, Dan Yan   +3 more
doaj   +1 more source

Proposed Etiotypes for Chronic Obstructive Pulmonary Disease: Controversial Issues [PDF]

Tuberculosis and Respiratory Diseases
The 2023 Global Initiative for Chronic Obstructive Lung Disease (GOLD) revised the definition of chronic obstructive pulmonary disease (COPD) to broadly include a variety of etiologies.
Sang Hyuk Kim, Ji-Yong Moon, Kyung Hoon Min, Hyun Lee   +3 more
doaj   +1 more source

What Single Cell RNA Sequencing Has Taught Us about Chronic Obstructive Pulmonary Disease [PDF]

Tuberculosis and Respiratory Diseases
Chronic obstructive pulmonary disease (COPD) affects close to 400 million people worldwide and is the 3rd leading cause of mortality. It is a heterogeneous disorder with multiple endophenotypes, each driven by specific molecular networks and processes ...
Don D. Sin
doaj   +1 more source

Effects of the Use of Beta-Blockers on Chronic Obstructive Pulmonary Disease Associated with Cardiovascular Comorbities: Systematic Review and Meta-analysis [PDF]

Tuberculosis and Respiratory Diseases
Cardiovascular comorbidity is common in individuals with chronic obstructive pulmonary disease (COPD). This factor interferes with pharmacological treatment. The use of β-blockers has been proposed for their known cardioprotective effects.
Natasha Cordeiro dos Santos, Aquiles Assunção Camelier, Anne Karine Menezes, Victor Durier Cavalcanti de Almeida, Roberto Rodrigues Bandeira Tosta Maciel, Fernanda Warken Rosa Camelier   +5 more
doaj   +1 more source

Clinical Characteristics, Risk Factors, and Outcomes of Acute Pulmonary Embolism in Thailand: 6-Year Retrospective Study [PDF]

Tuberculosis and Respiratory Diseases
Background Acute pulmonary embolism (APE) is a fatal disease with varying clinical characteristics and imaging. The aim of this study was to define the clinical characteristics, risk factors, and outcomes in patients with APE at a university hospital in ...
Pattarin Pirompanich, Ornnicha Sathitakorn, Teeraphan Suppakomonnun, Tunlanut Sapankaew   +3 more
doaj   +1 more source

Rhinovirus infection induces secretion of endothelin-1 from airway epithelial cells in both in vitro and in vivo models

Respiratory Research, 2023
Background Rhinovirus (RV) infection of airway epithelial cells triggers asthma exacerbations, during which airway smooth muscle (ASM) excessively contracts. Due to ASM contraction, airway epithelial cells become mechanically compressed.
Alane Blythe C. Dy, Jason Girkin, Antonella Marrocco, Adam Collison, Chimwemwe Mwase, Michael J. O’Sullivan, Thien-Khoi N. Phung, Joerg Mattes, Cynthia Koziol-White, James E. Gern, Yury A. Bochkov, Nathan W. Bartlett, Jin-Ah Park   +12 more
doaj   +1 more source

Mesenchymal stem cell-derived extracellular vesicles prevent the formation of pulmonary arterial hypertension through a microRNA-200b-dependent mechanism

Respiratory Research, 2023
Background Bone marrow mesenchymal stem cell-derived extracellular vesicles (BMSC-EVs) have been highly studied with their critical roles as carriers of therapeutic targets such as microRNAs (miRNAs) in the treatment of human diseases, including ...
Mengzhi Wan, Caiju Lu, Yu Liu, Feng Luo, Jing Zhou, Fei Xu   +5 more
doaj   +1 more source

Race-specific spirometry equations may overestimate asthma control in Black children and adolescents

Respiratory Research, 2023
Background A growing body of evidence suggests that use of race terms in spirometry reference equations underestimates disease burden in Black populations, which may lead to disparities in pulmonary disease outcomes.
Allison J. Burbank, Claire E. Atkinson, Andre E. Espaillat, Stephen A. Schworer, Katherine Mills, Jennifer Rooney, Ceila E. Loughlin, Wanda Phipatanakul, Michelle L. Hernandez   +8 more
doaj   +1 more source

Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: ORBE II study

Respiratory Research, 2023
Background The ORBE II study aimed to describe the characteristics and clinical outcomes of adult patients with severe eosinophilic asthma (SEA) treated with benralizumab in a real-world setting in Spain.
Alicia Padilla-Galo, Isabel Moya Carmona, Pilar Ausín, Luis Carazo Fernández, Ismael García-Moguel, José Luis Velasco-Garrido, Rubén Andújar-Espinosa, Francisco Casas-Maldonado, Eva Martínez-Moragón, Carlos Martínez Rivera, Elisabet Vera Solsona, Fernando Sánchez-Toril López, Andrea Trisán Alonso, Marina Blanco Aparicio, Marcela Valverde-Monge, Borja Valencia Azcona, Marta Palop Cervera, Javier Nuevo, Jesús Sánchez Tena, Gustavo Resler, Elisa Luzón, Alberto Levy Naon   +21 more
doaj   +1 more source

Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry

Respiratory Research, 2023
Background Achieving and maintaining a low-risk profile is associated with favorable outcome in pulmonary arterial hypertension (PAH). The effects of treatment on risk profile are variable among patients.
Agustin R. Garcia, Isabel Blanco, Lluis Ramon, Jesús Pérez-Sagredo, Francisco J. Guerra-Ramos, Clara Martín-Ontiyuelo, Olga Tura-Ceide, Francisco Pastor-Pérez, Pilar Escribano-Subías, Joan A. Barberà   +9 more
doaj   +1 more source